Arrhythmias in pregnancy (RCD code: VII‑V)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2016, Vol 2, Issue 6
Abstract
Cardiovascular diseases in pregnancy are the most common causes of maternal mortality in developed world and an important cause of heart failure, stroke, and arrhythmia. Cardiac disease complicates 0.4–4% of all pregnancies, and arrhythmias are among the most common cardiac complications [1]. In some cases, pregnancy triggers exacerbations of pre-existing arrhythmias, whereas in others it may manifest for the first time [2]. A prior history of arrhythmias or structural heart disease and family history of sudden death are the factors that matter to risk of tachyarrhythmias during pregnancy [3]. Due to extraordinary ethical considerations in pregnant women, there are only a few randomized studies and little data on efficacy or safety of antiarrhythmic drugs applied during pregnancy [4]. Therefore, much of clinical care is guided by general knowledge about hemodynamic changes in pregnant women, universal principles of treatment of arrhythmias and finally by gained experience in that area. Multi-disciplinary approach remains the overriding principle in management of pregnant woman with arrhythmias, including collaboration with gynecological and obstetric center. JRCD 2016; 2 (6): 177–180
Authors and Affiliations
Sylwia Wiśniowska-Śmiałek, Agata Leśniak-Sobelga, Magdalena Kostkiewicz, Piotr Podolec
Keywords
Related Articles
- EP ID EP248091
- DOI 10.20418/jrcd.vol2no6.208
- Views 101
- Downloads 0
Successful reversal of advanced heart failure due to peripartum cardiomyopathy with aggressive pharmacotherapy and a continuous‑flow left ventricular assist device (RCD code: III-1B.8c)
Peripartum cardiomyopathy (PPCM) is a rare but potentially devastating complication of pregnancy. PPCM is not well understood and relatively little is known about its epidemiology and pathogenesis. However, it appears to...
Establishing the optimal dose of nitric oxide in acute vasoreactivity testing in patients with pulmonary hypertension with use of the Bronchial Control Treatment System (RCD code: II)
The key point in the diagnostic algorithm for pulmonary hypertension plays the pulmonary reactivity testing, the agent most frequently used in the test is inhaled nitric oxide (iNO). Various dosages of iNO were used in a...
Double-chambered left ventricle in a young previously healthy man presenting for a routine echocardiographic study (RCD code: IV-1B.2o)
A double-chambered left ventricle (DCLV) constitutes a rare congenital malformation. It is usually diagnosed at a neonatal or pediatric age, and often exhibits mixed criteria for diverticulae and aneurysms. This anomaly...
New Frontiers in Interventional Cardiology 2013 – Highlights from the biggest workshop in Central and Eastern Europe
Since 1999, at the end of each year, cardiologists, interventional cardiologists and cardiac surgeons from all over the World meet in Cracow to discuss the most challanging topics in recent cardiology. From the beginning...
Rhythm disorders and electrocardiographic abnormalities in adult patients with pulmonary arterial hypertension (RCD code: class II)
Cardiac arrhythmias may occur in the course of pulmonary hypertension as a result of structural changes related to pressure overload, myocardial hypertrophy and chamber dilation. Arrhythmias compromise greatly to clinica...